Arixtra
fondaparinux sodium
- Strength
- 7.5 mg/.6mL
- Form
- Injection, Solution
- Class
- Factor Xa Inhibitor
Mylan Institutional LLC
Not stocked by us — reference only
Listed by Eugia US LLC
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Factor Xa Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 55150-230 |
| FDA application | ANDA206918 |
| RxNorm concept | 861356 |
| Package sizes listed | 2 |
| Marketed since | December 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
fondaparinux sodium
Mylan Institutional LLC
Not stocked by us — reference only
fondaparinux sodium
Mylan Institutional LLC
Not stocked by us — reference only
fondaparinux sodium
Mylan Institutional LLC
Not stocked by us — reference only
fondaparinux sodium
Mylan Institutional LLC
Not stocked by us — reference only
Dr. Reddy's Laboratories Limited
Not stocked by us — reference only
Dr. Reddy's Laboratories Limited
Not stocked by us — reference only
Eugia US LLC
Not stocked by us — reference only
Zydus Pharmaceuticals (USA) Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.